期刊文献+

血液透析患者丙型肝炎病毒感染的特点及防治 被引量:3

下载PDF
导出
摘要 1流行病学丙型肝炎病毒(hepatitis C virus,HCV)为一种单链RNA病毒,直径50~60nm,大约由9400个核苷酸组成。近似于人类黄热病病毒[1]。HCV的传播途径主要是输血和血液制品,性接触,经胎盘垂直传播的机会很少。与乙肝病毒相比,
出处 《中国血液净化》 2012年第8期409-412,共4页 Chinese Journal of Blood Purification
  • 相关文献

参考文献24

  • 1张小丽,朱蓓,喻荣彬,赵卫红.血液透析人群丙型肝炎病毒感染的多中心临床研究[J].中国血液净化,2011,10(8):429-432. 被引量:12
  • 2汪年松,盛晓华,张晓光,严艳,俞岗,崔勇平,唐令诠.维持性血液透析患者感染丙型病毒性肝炎126个月随访研究[J].中国血液净化,2009,8(11):593-596. 被引量:15
  • 3曹娅丽,王世相,郭苹,刘航.维持性血液透析患者丙型肝炎病毒感染的预防与预后观察[J].中国血液净化,2006,5(8):430-432. 被引量:15
  • 4Okamoto H,Okatla S,Sugiyama Y,et al.The5terminalsequence of hepatitis C virus genomeJpn J Exp,1997.
  • 5El-Sherif A,Elbahrawy A,Aboelfotoh A,et al.High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysisHemodial Int,2012.
  • 6Fabrizi F,Dulai G,Dixit V,Bunnapradist S,Martin P.Interferon for the treatment of chronic hepatitis C in dialysis patientsAlimentary Pharmacology and Therapeutics,2003.
  • 7Cooper CL,Druyts E,Thorlund K,et al.Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype1infection:an indirect comparison meta-analysisTher Clin Risk Manag,2012.
  • 8Tsui JI,Vittinghoff E,Shlipak MG,O’Hare AM.Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination SurveyJournal of the American Society of Nephrology,2006.
  • 9J.I. Tsui,E. Vittinghoff,M.G. Shlipak.Association of hepatitis C seropositivity with increased risk for developing end-stage renal diseaseArchives of Internal Medicine,2007.
  • 10Espinosa,M,Martin-Malo,A,de,Alvarez Lara,MA,Aljama,P.Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patientsNephrology Dialysis Transplantation,2001.

二级参考文献33

共引文献40

同被引文献23

  • 1魏来.亚太地区丙型肝炎病毒感染的诊断、处理和治疗共识[J].临床肝胆病杂志,2007,23(5):323-327. 被引量:11
  • 2Zahedi M], Darvish Moghaddam S, Alavian SM, et aL Se-: roprevalence of Hepatitis Viruses B, G, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran[]]. Hepat Mon, 2012, 12:339-343,.
  • 3Fontenele AM, Fi lho NS, Ferreira AS. Occult hepati tis B in patients on hemodialysis: a review[J], Ann Hepato l, 2013, 12: 527-531.
  • 4Dag lar D, Ergani A, Demirbakan H, et al . Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients[]]. Mikrobiyol Bu1,2014,48:143-150,.
  • 5Hinrichsen H, Leimenstoll G, Stegen G, et al . Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a mul ticentre study in 2796 patients[]]. Gut,2002,51:429-433.
  • 6Cartilho F], Moraes CR,Pinho ]R, et al. Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern BraziL Predictive risk factors for infection and molecular epidemiology[J]. BMC Public Health, 2004, 27:13-23,.
  • 7Launay 0, van der Vliet D, Rosenberg AR, et al. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults wi th HIV- 1: a randomized controlled trial[]]. ]AMA, 2011,305:1432-1440.
  • 8Hwang LY, Grimes CZ, Tran TQ, et al. Accelerated hepatitis B vaccination schedule among drJ.1g users: a randomized controlled t.r i al ].] ]. ] Infect Dis, 2010, 202: 1500-1509 .
  • 9北京市血液透析登记2012年度报告.乙型肝炎和丙型肝炎感染情况[J].中国血液净化,2012,11(增):26-28.
  • 10黄颂敏,陈肖蕾.血液透析中的乙型肝炎病毒感染[J].中国实用内科杂志,2008,28(1):25-27. 被引量:21

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部